Please login to the form below
Three steps forward, four steps back
How to ensure digital content achieves the right dialogue
Bringing the trial to the patient
By Gretchen Goller
-
Is it time for a more integrated and human-centric approach to Medical Affairs leadership?By Shairose Ebrahim
-
Rare disease trials Q&ABy Gretchen Goller and Valerie Legrand
-
Lonely planet: why there is dwindling value in pharma travelling aloneTo develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward
-
Accelerating diagnosis in rare diseaseBiopharmaceutical companies can drive effective partnerships and improve outcomes for all stakeholders and patients in the area of rare disease.
-
Accelerating innovationIpsen’s Alexandre Lebeaut on the French firm’s oncology plans, global focus and R&D approach
-
Janssen’s quest to prevent diseases taking holdJohan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Sinovac reveals positive preliminary data for COVID-19 vaccine
- Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK
- FDA approves Roche’s Actemra COVID-19 trial
- The best work in healthcare communications shines at virtual Communiqué Awards
- Mesoblast expands compassionate use COVID-19 programme
- Novavax gets $1.6bn from US government for coronavirus vaccine
- Biogen completes filing for highly-anticipated Alzheimer’s drug
- France’s Osivax raises over €30m for universal flu and coronavirus vaccines
- Lucid Group: Digital Delivery in Lockdown
- Live Webinar: The update of digital technologies in healthcare
- Live Webinar: Accelerating the Digital Health Economy through Innovation
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- A snapshot of… Exscientia
- ...
- Patients are ready for virtual clinical trials, are you?
- Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
- Keep your audiences close
- How getting up close and personal with target audiences can fuel creativity...
Quick links
Infographics
